What is the appropriate famotidine (Pepcid) dosing for a 17‑year‑old adolescent?

Famotidine (Pepcid) Dosing for a 17-Year-Old

For a 17-year-old adolescent, famotidine should be dosed at 1 mg/kg/day divided into two doses (maximum 40 mg/day), which typically translates to 20 mg twice daily for most adolescents in this age group. 1

FDA-Approved Dosing Framework

The FDA label specifies that famotidine 20 mg and 40 mg tablets are approved for pediatric patients weighing 40 kg or greater, using the same dosing regimens as adults 2. Since most 17-year-olds exceed 40 kg, they fall into this category and can use standard tablet formulations.

Indication-Specific Dosing (for patients ≥40 kg):

• Active duodenal or gastric ulcer: 40 mg once daily at bedtime OR 20 mg twice daily for up to 8 weeks 2
• Symptomatic non-erosive GERD: 20 mg twice daily for up to 6 weeks 2
• Erosive esophagitis: 20 mg twice daily OR 40 mg twice daily for up to 12 weeks 2
• Ulcer recurrence prevention: 20 mg once daily (though pediatric efficacy not established for this indication) 2

Pediatric-Specific Evidence

The pediatric guideline from the American Academy of Pediatrics recommends famotidine at 1 mg/kg/day divided into 2 doses for children aged 1-16 years 1. A pharmacokinetic study in children with gastroduodenal ulcers demonstrated that 0.5 mg/kg twice daily (maximum 40 mg/day) effectively healed ulcers within 8 weeks with no side effects 3.

For a 17-year-old, the practical approach is to use adult dosing (20 mg twice daily or 40 mg once daily) since they are at the upper end of the pediatric age range and typically meet the weight threshold. 2

Timing and Administration Considerations

• Famotidine can be taken with or without food 2
• For twice-daily dosing: administer in the morning and before bedtime 2
• For once-daily dosing: administer before bedtime 2
• May be given concurrently with antacids 2

Dose Adjustments for Renal Impairment

If the adolescent has moderate renal impairment (creatinine clearance 30-60 mL/min), reduce to 20 mg once daily or 40 mg every other day 2. For severe renal impairment (creatinine clearance <30 mL/min), reduce to 20 mg every other day 2.

Duration of Treatment

The FDA-approved treatment durations vary by indication: 6 weeks for symptomatic GERD, 8 weeks for active ulcers, and 12 weeks for erosive esophagitis 2. Clinical trials showed that most duodenal ulcers healed within 4 weeks, with an additional 2-4 weeks considered for non-responders 2.

Safety Profile

Famotidine has an excellent safety record with minimal side effects 4. Unlike cimetidine, it does not cause antiandrogenic effects or alter hepatic drug metabolism 5, 4. The H2-receptor antagonist class has been extensively studied in pediatrics and is considered safe, though tachyphylaxis can develop within 6 weeks of continuous use 1.

Clinical Pitfalls to Avoid

• Do not use famotidine tablets in patients weighing <40 kg as the 20 mg tablet exceeds recommended dosing; use oral suspension instead 2
• Recognize that H2-receptor antagonists are less effective than proton pump inhibitors for healing erosive esophagitis and symptom relief in severe GERD 1
• Be aware of rapid tachyphylaxis that limits long-term effectiveness, typically developing within 6 weeks 1
• Avoid assuming pediatric approval for all indications: ulcer recurrence prevention and pathological hypersecretory conditions lack established pediatric efficacy 2